Clinical Trial Update: D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions [Phase 4]

View source ↗

Summary

Phase 4 trial investigating D-Cycloserine augmentation of CBT for delusions in schizophrenia-spectrum conditions has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delusional Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: NYU Langone Health | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2018-07-09